Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Companyâs business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļSLP
āļāļ·āđāļāļāļĢāļīāļĐāļąāļSimulations Plus Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJun 18, 1997
āļāļĩāļāļĩāđāļO'Connor (Shawn M)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ212
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļJun 18
āļāļĩāđāļāļĒāļđāđ800 Park Offices Drive, Suite 401
āđāļĄāļ·āļāļRESEARCH TRIANGLE PARK
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ27709
āđāļāļĢāļĻāļąāļāļāđ16617237723
āđāļ§āđāļāđāļāļāđhttps://www.simulations-plus.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļSLP
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJun 18, 1997
āļāļĩāļāļĩāđāļO'Connor (Shawn M)
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Mr. Steven Chang
Global Head - Strategic Alliances
Global Head - Strategic Alliances
Dr. Viera Lukacova
Chief Scientific Officer
Mr. Erik Guffrey
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
Mr. Josh Fohey
Chief Operating Officer
Ms. Lisa Fortuna
Investor Relations
Mr. Murry Alper
Global Head - Medical Communications
Global Head - Medical Communications
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Mr. Steven Chang
Global Head - Strategic Alliances
Global Head - Strategic Alliances
Dr. Viera Lukacova
Chief Scientific Officer